NAKUP CEPIVA PCV 21 IN CEPIVA PROTI RSV
TED · 647838-2026Award noticeawardedNo deadline given
Value
Estimated€2,050,000 · 2,050,000 EUR
Awarded—
WinnerMerck Sharp & Dohme B.V.
Who already wins at this buyer
Firms with recorded awards from NACIONALNI INŠTITUT ZA JAVNO ZDRAVJE in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| MARITIM Zastopanje, trgovina in svetovanje d.o.o. Ljubljana | 1 | €7,971,356 | 2026-08-18 |
| AstraZeneca AB | 1 | — | 2026-06-22 |
| Merck Sharp & Dohme B.V. | 1 | — | 2026-09-21 |
| PROMED trgovanje in trženje z medicinskim materialom, d.o.o. | 1 | — | 2026-08-06 |
| Swixx Biopharma, trgovsko podjetje, d.o.o. | 1 | — | 2026-06-10 |
Full buyer profile: what NACIONALNI INŠTITUT ZA JAVNO ZDRAVJE buys and who wins it →
CPV codes
33651000 Medical equipment & pharmaceuticalsDescription
NAKUP CEPIVA PCV 21 IN CEPIVA PROTI RSV
Similar tenders
Closest by meaning — across languages, via embeddings.
| Published | Title | Buyer | Match |
|---|---|---|---|
| 2026-08-06 | NAKUP CEPIVA PROTI GRIPI | NACIONALNI INŠTITUT ZA JAVNO ZDRAVJE SI | 94% |
| 2026-06-22 | NAKUP ZDRAVIL PALIVIZUMAB IN CEPIVA PROTI TUBERKOLOZI | NACIONALNI INŠTITUT ZA JAVNO ZDRAVJE SI | 93% |
| 2026-04-30 | NAKUP DOLGO DELUJOČEGA MONOKLONSKEGA PROTITELESA PROTI RSV | NACIONALNI INŠTITUT ZA JAVNO ZDRAVJE SI | 93% |
| 2026-06-10 | NAKUP CEPIVA PROTI DAVICI, TETANUSU, OSLOVSKEM KAŠLJU IN OTROŠKI PARALIZI | NACIONALNI INŠTITUT ZA JAVNO ZDRAVJE SI | 91% |
| 2026-08-18 | Nakup potrošnega materiala za laboratorij programa SVIT | NACIONALNI INŠTITUT ZA JAVNO ZDRAVJE SI | 91% |
| 2026-08-13 | NAKUP ZDRAVIL - POZIV2 | UNIVERZITETNI KLINIČNI CENTER LJUBLJANA SI | 90% |